[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344893-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344893-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","diagnostic-accuracy-of-combinatorial-mrna-biomarkers-for-non-invasive-detection-and-therapy-monitoring-of-oral-and-oropharyngeal-scc","Diagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC","","Oral squamous cell carcinoma (OSCC) remains common worldwide and has poor prognosis, while reliable molecular biomarkers for early, non-invasive detection are still lacking. This pilot study used RNA sequencing on swab samples to find upregulated mRNA targets, then validated four candidates in 79 samples with RT-qPCR. A CombiROC analysis evaluated diagnostic performance, with further RT-qPCR and fluorescence staining on tumor and normal tissues to confirm RNA and protein expression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/diagnostic-accuracy-of-combinatorial-mrna-biomarkers-for-non-invasive-detection-and-therapy-monitoring-of-oral-and-oropharyngeal-scc/344893/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/diagnostic-accuracy-of-combinatorial-mrna-biomarkers-for-non-invasive-detection-and-therapy-monitoring-of-oral-and-oropharyngeal-scc/344893.png","ImageObject",300,407,{"name":42,"@type":43},"Ava Thompson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of the study?","Question",{"text":63,"@type":64},"To assess the diagnostic accuracy of a combinatorial mRNA biomarker panel for non-invasive detection and therapy monitoring in oral and oropharyngeal SCC.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were potential biomarkers identified and validated?",{"text":68,"@type":64},"RNA sequencing was used to identify upregulated mRNA targets in swab samples, followed by RT-qPCR validation of candidates in 79 samples.",{"name":70,"@type":61,"acceptedAnswer":71},"Which biomarker panel performed best and how was it evaluated?",{"text":72,"@type":64},"A panel of three markers (c-JUN, SFN, HSP90AB1) showed high performance, with specificity and sensitivity of 92.3% and an AUC of 0.91, assessed by CombiROC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344893,1790634277,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","British Journal of Cancer [www.nature.com/bjc](www.nature.com/bjc)  \nARTICLE OPEN   \nMolecular Diagnostics  \nDiagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC  \nLeonie Hose 1 ✉ , Alina Celine Tekin1, Bart Verwaaijen2, Rayoung Kim1, Christian Rückert-Reed 3,4, Ulrich Hamberger5, Tobias Busche 3,4, Lars-Uwe Scholtz1, Frank Brasch5, Ingo Todt1, Peter Goon6 and Matthias Schürmann 1  \n© The Author(s) 2026  \nBACKGROUND: Oral squamous cell carcinoma (OSCC) is increasingly common, with over 380,000 new cases annually. Despite its high incidence (6.0 per 100,000 males; 2.3 per 100,000 females) and poor prognosis, no molecular biomarkers exist for early detection. Non-invasive sampling could improve diagnosis and patient outcomes.  \nMETHODS: This pilot study used RNA sequencing to identify signiﬁcantly upregulated mRNA targets in swab samples from oral and oropharyngeal SCC patients and healthy probands. After ﬁltering, four potential biomarkers were further validated in 79 samples using RT-qPCR. CombiROC analysis assessed diagnostic performance. Additional RT-qPCR on tumour and normal tissues and ﬂuorescence staining in FFPE tumour sections evaluated expression at mRNA and protein levels.  \nRESULTS: A panel of three markers (c-JUN, SFN, HSP90AB1) showed high diagnostic accuracy: 92.3% speciﬁcity, 92.3% sensitivity, and AUC of 0.91 . Fluorescence staining conﬁrmed signiﬁcantly higher protein expression in tumour tissues, supporting RNA ﬁndings. The panel showed stronger diagnostic performance in men than in women.  \nCONCLUSION: This study presents a promising non-invasive biomarker panel for oral and oropharyngeal SCC detection. Further validation in larger cohorts is needed to conﬁrm diagnostic value and clarify sex speciﬁcity. The approach is adaptable to other tumour types and sample materials, supporting molecular diagnostics.  \nBritish Journal of Cancer (2026) 134:961–974; [https://doi.org/10.1038/s41416-025-03313-w](https://doi.org/10.1038/s41416-025-03313-w)  \nBACKGROUND  \nHead and neck tumours, particularly oral squamous cell carcinomas (OSCC), represent a signiﬁcant health challenge worldwide and remain a highly dynamic, multifaceted disease with global signiﬁcance. OSCC accounts for over 90% of all malignancies within the oral cavity, with an annual incidence exceeding approximately 390,000 new cases [1] globally. The incidence and prognosis of OSCC show notable sex-related differences. Epidemiological studies consistently report a higher prevalence of OSCC in males compared to females, with a male-to-female ratio of for example 2.2:1 global and 2.7:1 in Germany [2] . Key risk factors include tobacco and alcohol consumption, and human papillomavirus (HPV) infection. Especially for oropharyngeal SCC HPV infection plays an important role, e.g. HPV high-risk strains, like HPV16 and HPV18, have been identiﬁed as substantial risk factors for the younger population [3, 4] . For SCC of the tongue and tonsils, traditionally p16 immunohistochemistry is used as a  \nreliable surrogate marker for HPV determination [5] . Tobacco, in both combustible and non-combustible forms, is strongly associated with OSCC, as it contains carcinogenic compounds that damage the oral mucosa[6, 7] . Other factors include poor oral hygiene and dietary deﬁciencies, which can exacerbate the risk of OSCC [8] . Oral and oropharyngeal SCC are often diagnosed at a late stage, necessitating major surgical interventions in critical regions of the mouth and throat, and these can have enormous consequences for a patient’s quality of life [9] . Thus, timely and accurate diagnostic techniques are essential in improving patient outcomes in the future. The current diagnostic gold standard for OSCC involves tissue biopsies followed by histopathological evaluation. Sampling tissue biopsies is invasive, anaesthetics must be administered, and it can result in patient discomfort, delays in treat","cbCaisKq97LSzdIP","https://ap.wps.com/l/cbCaisKq97LSzdIP","pdf",2192349,14,"English","# Background\n## Oral and oropharyngeal SCC and the need for non-invasive biomarkers\n# Methods\n## RNA sequencing and RT-qPCR validation\n## Expression confirmation in tumor and normal tissues\n# Results\n## Diagnostic accuracy of the biomarker panel\n## Sex-related differences in performance\n# Conclusion\n## Non-invasive biomarker panel and need for further validation","[{\"question\":\"What was the main goal of the study?\",\"answer\":\"To assess the diagnostic accuracy of a combinatorial mRNA biomarker panel for non-invasive detection and therapy monitoring in oral and oropharyngeal SCC.\"},{\"question\":\"How were potential biomarkers identified and validated?\",\"answer\":\"RNA sequencing was used to identify upregulated mRNA targets in swab samples, followed by RT-qPCR validation of candidates in 79 samples.\"},{\"question\":\"Which biomarker panel performed best and how was it evaluated?\",\"answer\":\"A panel of three markers (c-JUN, SFN, HSP90AB1) showed high performance, with specificity and sensitivity of 92.3% and an AUC of 0.91, assessed by CombiROC.\"}]","Diagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC | PDF",1790055660,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7073567e76fdb27cccda287098d57ebe.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e42ec27de2001e537f5af9c7f511e89c.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50bc023fe485c1deb05c2988cb96cc62.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9347726e03ea5e06beb18326a1f7935.webp",980,1301]